Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
|
Alemtuzumab |
CD52 |
|
|
CLL, MS treatment |
Alemtuzumab |
|
|
Bevacizumab |
VEGF |
|
|
Colorectal cancel, renal cell carcinoma |
Bevacizumab |
|
|
Cetuximab |
EGFR |
|
|
Stage IV colorectal cancer, head and neck cancer |
Cetuximab |
|
|
Rituximab |
CD20 |
|
|
B-cell non-Hodgkin lymphoma, CLL, Rheumatoid arthritis, ITP |
Rituximab |
|
|
Trastuzumab |
HER2/neu |
|
|
Breast cancer |
Trastuzumab |
|
|
Adalimumab, certolizumab, infliximab |
Soluble TNF-alpha |
|
|
IBD, rheumatoid arthritis, ankylosing spondylitis, psoriasis
|
Adalimumab, certolizumab, infliximab |
|
|
Eculizumab |
Complement protein C5 |
|
|
Paroxysmal nocturnal hemoglobinuria |
Eculizumab |
|
|
Natalizumab |
alpha-4integrin |
|
|
Multiple sclerosis, Crohn disease |
Natalizumab |
|
|
Decoy TNF-alpha receptor and not a monoclonal antibody |
Etarnecept |
|
|
WBC adhesion Risk of PML in patients with JC virus |
Natalizumab |
|
|
Abciximab |
Platelet glycoproteins IIb/IIIa |
|
|
Anti platelet agent for prevention of ischemic complications in patients undergoing percutaneous coronary intervention |
Abciximab |
|
|
Denosumab |
RANKL |
|
|
Osteoporosis; inhibit osteoclast maturation (mimics osteoprotegerin) |
Denosumab |
|
|
Digoxin immune Fab |
Digoxin |
|
|
Antidote for digoxin toxicity |
Digoxin immune Fab |
|
|
Omalizumab |
IgE |
|
|
Allergic asthma; prevents IgE binding to FceRI |
Omalizumab |
|
|
Palivizumab |
RSV F protein |
|
|
RSV prophylaxis for high-risk infants |
Palivizumab |
|
|
Ranibizumab, bevacizumab |
VEGF |
|
|
Neovascular age-related macular degeneration |
Ranibizumab, bevacizumab |
